Qsymia is a weight loss drug that has been approved in the United States since 2012 for patients with a BMI of 30 or more who have at least one weight-related health condition. The combination of diet, exercise, and Qsymia has been clinically proven to lower weight by as much as 32 pounds or more over the course of 56 weeks.
Taken once per day, Qsymia can help you control hunger and resist cravings. Qsymia contains a combination of phentermine, which reduces appetite, and topiramate, which can help you feel full as well as change the taste of some foods to make you less likely to want to eat them.
Obesity is one of the leading causes of death in the United States. Affecting over 42% of adults, obesity can lead to a multitude of health conditions including type 2 diabetes and heart disease.
There is currently no generic version available for Qsymia, but the patent expires in June 2020, meaning generics may be available soon. Until then, it’s very much possible to get a discount on the name brand if you know where to look.